GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (FRA:BUWA) » Definitions » Shiller PE Ratio

Bio-Rad Laboratories (FRA:BUWA) Shiller PE Ratio : 10.34 (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Bio-Rad Laboratories Shiller PE Ratio?

As of today (2024-05-14), Bio-Rad Laboratories's current share price is €260.70. Bio-Rad Laboratories's E10 for the quarter that ended in Mar. 2024 was €25.21. Bio-Rad Laboratories's Shiller PE Ratio for today is 10.34.

The historical rank and industry rank for Bio-Rad Laboratories's Shiller PE Ratio or its related term are showing as below:

FRA:BUWA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.22   Med: 28.46   Max: 62.22
Current: 10.57

During the past years, Bio-Rad Laboratories's highest Shiller PE Ratio was 62.22. The lowest was 10.22. And the median was 28.46.

FRA:BUWA's Shiller PE Ratio is ranked better than
86.52% of 282 companies
in the Medical Devices & Instruments industry
Industry Median: 27.505 vs FRA:BUWA: 10.57

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bio-Rad Laboratories's adjusted earnings per share data for the three months ended in Mar. 2024 was €12.374. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €25.21 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bio-Rad Laboratories Shiller PE Ratio Historical Data

The historical data trend for Bio-Rad Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Shiller PE Ratio Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.46 25.58 19.84 15.41 12.58

Bio-Rad Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.18 15.75 14.52 12.58 12.81

Competitive Comparison of Bio-Rad Laboratories's Shiller PE Ratio

For the Medical Devices subindustry, Bio-Rad Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Shiller PE Ratio falls into.



Bio-Rad Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bio-Rad Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=260.70/25.21
=10.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Rad Laboratories's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Bio-Rad Laboratories's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12.374/129.4194*129.4194
=12.374

Current CPI (Mar. 2024) = 129.4194.

Bio-Rad Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.802 100.560 1.032
201409 0.303 100.428 0.390
201412 1.087 99.070 1.420
201503 0.564 99.621 0.733
201506 0.864 100.684 1.111
201509 0.526 100.392 0.678
201512 1.542 99.792 2.000
201603 0.377 100.470 0.486
201606 0.543 101.688 0.691
201609 0.552 101.861 0.701
201612 -0.664 101.863 -0.844
201703 0.383 102.862 0.482
201706 0.151 103.349 0.189
201709 0.612 104.136 0.761
201712 1.960 104.011 2.439
201803 17.655 105.290 21.701
201806 7.593 106.317 9.243
201809 7.619 106.507 9.258
201812 -24.507 105.998 -29.922
201903 25.435 107.251 30.692
201906 17.576 108.070 21.048
201909 -7.881 108.329 -9.415
201912 16.479 108.420 19.671
202003 20.562 108.902 24.436
202006 28.549 108.767 33.970
202009 37.050 109.815 43.664
202012 22.860 109.897 26.921
202103 27.199 111.754 31.498
202106 25.166 114.631 28.413
202109 110.466 115.734 123.528
202112 -46.542 117.630 -51.207
202203 -102.150 121.301 -108.987
202206 -29.373 125.017 -30.407
202209 -5.535 125.227 -5.720
202212 26.224 125.222 27.103
202303 2.167 127.348 2.202
202306 -36.542 128.729 -36.738
202309 3.411 129.860 3.399
202312 11.132 129.419 11.132
202403 12.374 129.419 12.374

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bio-Rad Laboratories  (FRA:BUWA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bio-Rad Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (FRA:BUWA) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (FRA:BUWA) Headlines

No Headlines